Tower Research Capital (TRC)’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.6K | Buy |
1,206
+32
| +3% | +$566 | ﹤0.01% | 3493 |
|
|
2025
Q4 | $22K | Buy |
1,174
+4
| +0.3% | +$66 | ﹤0.01% | 3026 |
|
|
2025
Q3 | $17.1K | Sell |
1,170
-3,843
| -77% | -$48.6K | ﹤0.01% | 3447 |
|
|
2025
Q2 | $55.3K | Buy |
5,013
+781
| +18% | +$7.59K | ﹤0.01% | 2888 |
|
|
2025
Q1 | $37.8K | Sell |
4,232
-8,438
| -67% | -$78.5K | ﹤0.01% | 2437 |
|
|
2024
Q4 | $119K | Buy |
12,670
+7,452
| +143% | +$67.8K | ﹤0.01% | 2058 |
|
|
2024
Q3 | $42.1K | Sell |
5,218
-4,571
| -47% | -$39.6K | ﹤0.01% | 2815 |
|
|
2024
Q2 | $83K | Buy |
9,789
+9,391
| +2,360% | +$84.8K | ﹤0.01% | 2713 |
|
|
2024
Q1 | $3.57K | Sell |
398
-22,936
| -98% | -$213K | ﹤0.01% | 4837 |
|
|
2023
Q4 | $262K | Buy |
23,334
+18,607
| +394% | +$187K | ﹤0.01% | 1878 |
|
|
2023
Q3 | $40.8K | Buy |
4,727
+712
| +18% | +$6.87K | ﹤0.01% | 2719 |
|
|
2023
Q2 | $41.6K | Buy |
4,015
+2,157
| +116% | +$23.8K | ﹤0.01% | 2738 |
|
|
2023
Q1 | $20K | Sell |
1,858
-64
| -3% | -$677 | ﹤0.01% | 3449 |
|
|
2022
Q4 | $21K | Sell |
1,922
-7,955
| -81% | -$83.6K | ﹤0.01% | 3105 |
|
|
2022
Q3 | $100K | Buy |
9,877
+7,360
| +292% | +$69K | ﹤0.01% | 2561 |
|
|
2022
Q2 | $23K | Buy |
2,517
+983
| +64% | +$9.06K | ﹤0.01% | 3670 |
|
|
2022
Q1 | $15K | Sell |
1,534
-215
| -12% | -$2.11K | ﹤0.01% | 3839 |
|
|
2021
Q4 | $19K | Sell |
1,749
-1,760
| -50% | -$15.3K | ﹤0.01% | 3745 |
|
|
2021
Q3 | $26K | Buy |
3,509
+485
| +16% | +$5.42K | ﹤0.01% | 3490 |
|
|
2021
Q2 | $44K | Buy |
3,024
+650
| +27% | +$12.2K | ﹤0.01% | 3130 |
|
|
2021
Q1 | $48K | Buy |
2,374
+943
| +66% | +$17.9K | ﹤0.01% | 3163 |
|
|
2020
Q4 | $25K | Sell |
1,431
-34,916
| -96% | -$627K | ﹤0.01% | 3731 |
|
|
2020
Q3 | $537K | Buy |
36,347
+28,108
| +341% | +$527K | 0.01% | 1605 |
|
|
2020
Q2 | $173K | Buy |
+8,239
| New | +$212K | 0.01% | 1923 |
|
|
2020
Q1 | – | Sell |
-3,094
| Closed | -$80K | – | 3866 |
|
|
2019
Q4 | $80K | Buy |
3,094
+1,296
| +72% | +$25.2K | 0.01% | 1067 |
|
|
2019
Q3 | $35K | Buy |
1,798
+732
| +69% | +$14.8K | ﹤0.01% | 2051 |
|
|
2019
Q2 | $17K | Sell |
1,066
-1
| -0.1% | -$20 | ﹤0.01% | 2279 |
|
|
2019
Q1 | $25K | Buy |
1,067
+667
| +167% | +$16.9K | ﹤0.01% | 2150 |
|
|
2018
Q4 | $10K | Buy |
+400
| New | +$10.8K | ﹤0.01% | 2483 |
|
|
2018
Q3 | – | Sell |
-523
| Closed | -$12K | – | 4235 |
|
|
2018
Q2 | $12K | Sell |
523
-137
| -21% | -$3.25K | ﹤0.01% | 2707 |
|
|
2018
Q1 | $16K | Buy |
660
+114
| +21% | +$3.13K | ﹤0.01% | 2278 |
|
|
2017
Q4 | $15K | Sell |
546
-6,108
| -92% | -$181K | ﹤0.01% | 2284 |
|
|
2017
Q3 | $227K | Buy |
6,654
+5,463
| +459% | +$179K | 0.02% | 680 |
|
|
2017
Q2 | $47K | Buy |
1,191
+969
| +436% | +$37.3K | 0.01% | 782 |
|
|
2017
Q1 | $8K | Buy |
222
+139
| +167% | +$4.44K | ﹤0.01% | 1935 |
|
|
2016
Q4 | $3K | Buy |
+83
| New | +$2.58K | ﹤0.01% | 3293 |
|
|
2016
Q3 | – | Sell |
-229
| Closed | -$5K | – | 4423 |
|
|
2016
Q2 | $5K | Buy |
+229
| New | +$4.95K | ﹤0.01% | 3415 |
|
|
2016
Q1 | – | Sell |
-124
| Closed | -$2K | – | 4914 |
|
|
2015
Q4 | $2K | Buy |
+124
| New | +$1.97K | ﹤0.01% | 3806 |
|
|
2015
Q2 | – | Sell |
-10
| Closed | – | – | 5023 |
|
|
2015
Q1 | $0 | Buy |
+10
| New | +$183 | ﹤0.01% | 4926 |
|
|
2014
Q4 | – | Sell |
-42
| Closed | -$1K | – | 4677 |
|
|
2014
Q3 | $1K | Sell |
42
-132
| -76% | -$3.83K | ﹤0.01% | 4153 |
|
|
2014
Q2 | $6K | Buy |
+174
| New | +$5.24K | ﹤0.01% | 2746 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
